Stephen Thorne
FounderCo-founder & Chief Scientific Officer at KaliVir Immunotherapeutics
Greater Pittsburgh Region
FoundedKaliVir Immunotherapeutics
About
Stephen Thorne is Chief Scientific Officer at KaliVir Immunotherapeutics. He has more than 15 years of research and leadership experience in the pre-clinical and translational development of cancer immunotherapies, including immune cell-based therapies, oncolytic viral therapies, and gene therapy. His areas of expertise include immunocompetent mouse cancer models, non-invasive molecular imaging in animal models, process development for complex biological therapies, and the development of immune monitoring and immune assays.
Co-founder & Chief Scientific Officer at KaliVir Immunotherapeutics
Intro paths
→
In turn, Stephen can intro founders to KaliVir Immunotherapeutics's investors below.
KaliVir Immunotherapeutics's investors · 1
Experience
- KaliVir ImmunotherapeuticsChief Scientific Officercurrent2020 — present
- Duo OncologyBoard Membercurrent2020 — present
- Western Oncolytics Ltd.Chief Scientific Officercurrent2016 — presentGreater Pittsburgh Area
- University of PittsburghAssistant Professor
- Stanford UniversityResearch Associate2003 — 2007
- Cancer Research UKPostDoc2000 — 2002London, United Kingdom
Skills & more
Molecular Biology7Cell Culture4Cell Biology4Biochemistry2Animal Models3Lifesciences1Microscopy2Cell8Cancer8PCR1Genetics2Immunology2
+2 more
Cancer ResearchDrug DiscoveryFrom Stephen's professional profile.
Frequently asked questions
- Who is Stephen Thorne?
- Stephen Thorne is Chief Scientific Officer at KaliVir Immunotherapeutics. He has more than 15 years of research and leadership experience in the pre-clinical and translational development of cancer immunotherapies, including immune cell-based therapies, oncolytic viral therapies, and gene therapy. His areas of expertise include immunocompetent mouse cancer models, non-invasive molecular imaging in animal models, process development for complex biological therapies, and the development of immune monitoring and immune assays.
- Where does Stephen Thorne work?
- Stephen Thorne is Co-founder & Chief Scientific Officer of KaliVir Immunotherapeutics.
- What companies did Stephen Thorne found?
- Stephen Thorne founded KaliVir Immunotherapeutics.
- Where did Stephen Thorne go to school?
- Stephen Thorne studied at Imperial College London (Doctor of Philosophy (Ph.D.), Microbiology); University of Oxford (Bachelor of Applied Science (B.A.Sc.), Biochemistry).
Same school
Also attended Imperial College London643
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi
+ 637 more
Also attended University of Oxford1,334
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 1,328 more
Shared employers
Also worked at University of Pittsburgh41
Matt GurinDirector, Finance and Operations at RRE VenturesRyan FrisbiePartner at VIEWPOINT VENTURESMichael HennesseyVenture Partner at DrivenVibhu MittalGen AI at SenseAI VenturesStacie McCarthyExecutive Assistant at Standard CryptoJason RobinsSpecial Advisor at Data Point Capital
+ 35 more
Also worked at Stanford University868
Ann Miura-KoCo-founding Partner at FloodgateBalaji SrinivasanAngel investor and founder of The Network SchoolMartin CasadoGeneral Partner at Andreessen HorowitzMike KriegerCo-founder of Instagram; Chief Product Officer at AnthropicAndy FangCo-founder & CTO of DoorDashRyan SheaCo-founder of Blockstack (Stacks)
+ 862 more
Also worked at Cancer Research UK31
Drew BurdonInvestor at LSP (Life Sciences Partners)Giovanni MariggiInvestor at MedicxiDominic SchmidtGeneral Partner at Advent Life SciencesJoanna SorokaInvestment Partner at Hitachi VenturesMilenko CicmilVenture Partner at Cure VenturesMartin TaylorPrincipal at F-Prime Capital Partners
+ 25 more